Clinical trial

Adverse Events and Genomics in Schizophrenia

NCT01966588

StatusUNKNOWN

Study typeOBSERVATIONAL

Start date2013-06-01

PhaseN/A

Study timeline

Study start (unknown)2013-06-01Date precision: month

Registry last updated2016-06-01

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Adverse Effect of Other Antipsychotics and Neurolepticsunresolved

Interventions

Blood samples for whole genomic/transcriptomic sequencingOTHER

UKU Side Effect Rating ScaleOTHER

Sponsors & collaborators

University of British Columbialead sponsor

Vancouver Coastal Healthcollaborator

Icahn School of Medicine at Mount Sinaicollaborator

Mapped research locations

VancouverBritish Columbia, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01966588 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.